BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Benne N, Ter Braake D, Stoppelenburg AJ, Broere F. Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases. Front Immunol 2022;13:864403. [PMID: 35392079 DOI: 10.3389/fimmu.2022.864403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Firdessa Fite R, Bechi Genzano C, Mallone R, Creusot RJ. Epitope-based precision immunotherapy of Type 1 diabetes. Hum Vaccin Immunother 2023;19:2154098. [PMID: 36656048 DOI: 10.1080/21645515.2022.2154098] [Reference Citation Analysis]
2 Zala A, Thomas R. Antigen-specific immunotherapy to restore antigen-specific tolerance in Type 1 diabetes and Graves' disease. Clin Exp Immunol 2023;211:164-75. [PMID: 36545825 DOI: 10.1093/cei/uxac115] [Reference Citation Analysis]
3 Shuai Z, Zheng S, Wang K, Wang J, Leung PSC, Xu B. Reestablish immune tolerance in rheumatoid arthritis. Front Immunol 2022;13:1012868. [DOI: 10.3389/fimmu.2022.1012868] [Reference Citation Analysis]
4 Nepom GT. Synergistic targeting of immunologic pathways to empower durable tolerance therapies. Front Immunol 2022;13:962177. [DOI: 10.3389/fimmu.2022.962177] [Reference Citation Analysis]